Metabolism and Excretory of HSK21542 in Maintenance Hemodialysis Patients

NCT06238388 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Kidney Disease Patients

Interventions

DRUG: HSK21542 Injection

Sponsor

Haisco Pharmaceutical Group Co., Ltd.